In Brief

This week's section

+ See all authors and affiliations

Science  06 Feb 2015:
Vol. 347, Issue 6222, pp. 590-592
DOI: 10.1126/science.347.6222.590

You are currently viewing the summary.

View Full Text

Summary

In science news around the world, molecular diagnostics company Myriad Genetics ends a long battle to defend its controversial patents on genetic tests for cancer risk, police search the Max Planck Institute for Biological Cybernetics in response to accusations of animal mistreatment by activists, researchers funded by the pharmaceutical company Roche—which makes Tamiflu—found that the drug helps combat influenza, a fire at the Russian Academy of Sciences destroys a significant portion of its documents, and the U.K. House of Commons votes overwhelmingly to allow researchers to pursue a fertility treatment called mitochondrial DNA replacement therapy. Also, the European Commission's former (and first) chief science adviser, microbiologist Anne Glover, tells reporters she doesn't regret saying that opposing genetically modified crops is a form of madness. And the first Science Ball opens its doors to debutantes and doctorates in Vienna, home of the waltz and of balls.